[{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/cancers.ts","type":"changed","fields":[{"field":"burden","before":"\"~300,000 CNS tumours per year; glioblastoma median survival ~15 months.\"","after":"\"About 300,000 CNS tumours occur per year; glioblastoma median survival is about 15 months.\""},{"field":"tldr","before":"\"The most lethal brain tumour, barely improved since 2005. Low-grade IDH-mutant gliomas, by contrast, got their first targeted drug in 2024.\"","after":"\"Glioblastoma is the most lethal brain tumour, barely improved since 2005. Low-grade IDH-mutant gliomas, by contrast, got their first targeted drug in 2024.\""}]},{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/","commit":"cebb34a709","date":"2026-09-08","author":"Jude Gomila","message":"Guideline mapping on every standard-of-care row; sourced biomarker prevalence for 59 targets; GuidelineChip, PrevalenceTable, CancerPrevalen","file":"src/data/cancers.ts","type":"changed","fields":[{"field":"standardOfCare","before":"[\n      { setting: \"Glioblastoma\", approach: \"Resection → RT + temozolomide → TTFields; lomustine/bevacizumab at relapse.\", refs: [\"fluorescence-guided-surgery\", \"imrt-igrt\", \"optune\"] },\n      { setting: \"IDH-mutant ...","after":"[\n      { setting: \"Glioblastoma\", approach: \"Resection → RT + temozolomide → TTFields; lomustine/bevacizumab at relapse.\", refs: [\"fluorescence-guided-surgery\", \"imrt-igrt\", \"optune\"], guideline: { version: \"NCCN Gui..."}]},{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/","commit":"815a2a8bae","date":"2026-09-05","author":"Jude Gomila","message":"OnCo: open map of oncology — corpus (642 objects, 14 kinds), graph, static site, API, TNBC spike","file":"src/data/cancers.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"group"},{"field":"wikipedia"},{"field":"burden"},{"field":"tldr"},{"field":"summary"},{"field":"biomarkers"},{"field":"standardOfCare"},{"field":"stateOfArt"},{"field":"history"},{"field":"pipeline"},{"field":"openProblems"},{"field":"targets"},{"field":"technologies"},{"field":"tags"}]}]